Sentio BioSciences LLC reposted this
The API Innovation Center has awarded a contract to Missouri-based Sentio BioSciences LLC to advance the development and domestic production of two critical pharmaceutical molecules that have historically faced shortages. This collaboration marks a major milestone in reshoring API production, enhancing national health security and ensuring a reliable supply of essential medications. Sentio brings over 15 years of expertise in pharmaceutical innovation to commercial manufacturing, having developed and scaled complex APIs and FDA-approved drug products. This collaboration with APIIC will accelerate the reshoring of these critical molecules while ensuring compliance with the highest regulatory standards. This initiative exemplifies APIIC's commitment to working with members of our ecosystem like Sentio to address national health security needs while advancing innovation, economic growth and job placement in Missouri and beyond. Read the full press release on our website: https://lnkd.in/dSXMxatr #PharmaceuticalManufacturing #SupplyChainResilience #Innovation #APIInnovationCenter #PublicPrivatePartnerships
This is a big milestone and we are happy to be working with you!
API Innovation Center thanks for the opportunity to collaborate with you on this critical initiative of manufacturing essential medicines! Sentio BioSciences LLC is excited about this effort & looking forward to delivering successfully!
Great news for the industry and St. Louis! Congrats to you!
Congratulations Flavia and Karthik!
Pharmaceutical Consultant
3wCongratulations to both parties. This is great step towards reshoring.